Cranberry Supplements: PAC Dose, Form, and What the Evidence Shows

Here is the honest answer first. The strongest evidence on cranberry is the 2023 Cochrane review, which included 50 randomized trials and 8,857 participants. Of those, 26 trials covering 6,211 participants could be pooled, and they found a moderate-certainty reduction in the risk of symptomatic, culture-verified urinary tract infection, with a risk ratio of 0.70 (95% CI 0.58 to 0.84) [1]. It is a real finding, and it is narrower than the way cranberry is usually sold. It appears in some groups and not others, it depends on a dose most labels never declare, and it answers a prevention question, not a treatment one.

What a Cranberry Supplement Actually Is

A cranberry supplement is a concentrated form of the American cranberry, Vaccinium macrocarpon, sold as capsules, tablets, softgels, gummies, or powder [7]. You cannot eat or drink enough whole cranberry to match the amounts used in research, so the supplement form concentrates the fruit into something practical to take daily.

The number on the bottle describes that fruit material, usually as whole-fruit powder or as a concentrated extract. The FDA's own claim is written around the first kind, specifying cranberry fruit powder that is 100 percent fruit [4].

The compound researchers actually study is a class of polyphenols called proanthocyanidins, or PACs. Cranberry's PACs are the compounds the research keeps returning to, and PAC content is what the 2024 meta-analysis found predictive of whether a product does anything at all [2].

So two numbers live inside every cranberry product: the fruit-powder weight on the label, and the PAC content the research measures. Most bottles report only the first. That gap is the subject of this guide.

The Mechanism: Anti-Adhesion, Not Antibacterial

Cranberry's PACs interfere with bacterial adhesion to the urothelial lining, the surface inside your urinary tract, which makes cranberry an anti-adhesion strategy rather than an antibacterial one [7].

The bacteria most often involved, E. coli, use hair-like appendages to grip that lining before they can establish a foothold. Cranberry PACs interfere with the gripping, making the surface harder to hold, so more bacteria leave with the next void. WebMD's medical review states the mechanism the same way [7].

Notice what this does not do. It does not kill bacteria. An antibiotic kills; cranberry PACs interrupt adhesion. That is why cranberry is a prevention question: it may make it harder for bacteria to gain a foothold over months of daily use, and it cannot clear an infection already established. NCCIH's own guidance agrees: cranberry is not recommended as a treatment for an existing urinary tract infection [5].

Every claim in this article is about reducing the opportunity for bacteria to adhere, never about treating a problem that already exists.

The Dose Question: 36 mg of PACs per Day

The clearest dose signal in the cranberry literature is a threshold of 36 mg of PACs per day, reported in a 2024 meta-analysis in Frontiers in Nutrition [2].

That review pooled 10 randomized trials and separated them by PAC dose. Low-PAC products did not produce a clear benefit, and higher-PAC products did.

Two Reviews, Two Different Answers on Dose

The two headline reviews do not agree about dose, and that disagreement is exactly why the label matters.

Cochrane's 2023 review could not detect a dose relationship at all. Its text states that it is unclear whether efficacy differs between cranberry juice and tablets, or between different doses of PACs, because the certainty of the evidence was very low. No difference in the risk of urinary tract infections could be demonstrated between low, moderate, and high doses of PACs [1].

The 2024 meta-analysis, restricted to trials that actually reported PAC intake, reached a different conclusion. It detected a threshold at 36 mg of PACs per day, with nothing significant below it, and found the effect more clearly in subgroups of women, at a risk ratio of 0.84 (95% CI 0.71 to 0.98). That female-only result did not survive correction for multiple comparisons, so treat it as a hint rather than a finding [2].

Do not read the 36 mg threshold as settled science. It is the best current answer from the trials that measured PACs, and it conflicts directly with Cochrane's finding of no demonstrable dose relationship. The two reviews ask the same question and land in different places, largely because they pooled different trials and graded the evidence differently.

When the reviewers cannot agree on the dose, the number printed on the bottle becomes the only thing you can check for yourself.

Why Your Label Does Not Tell You the PAC Dose

Cranberry labels declare milligrams of fruit powder, not milligrams of PACs, so the number that predicts the research result is usually not printed at all [8].

A bottle can say "cranberry concentrate 500 mg" or "cranberry fruit powder 400 mg" and still tell you nothing about the PACs inside. The same fruit weight can carry very different PAC amounts depending on the fruit, the harvest, and the processing.

Cochrane says this plainly in its own plain-language summary. It states that there is no established regimen for what PAC dose to use, that there is no formal regulation by health authorities of cranberry products, and that "the dose suggested may not be included on the package" [8].

Read that again, because it is a research organization making the point, not a skeptic. One review cannot confirm that dose matters, another finds a clear threshold, and the label reports neither. When the experts disagree about dose, the only thing you can do is find out what is in the bottle.

The question to ask of any cranberry product is simple:

1. Does the label declare a PAC figure, or a standardization to a set percentage of PACs?
2. If not, can the manufacturer tell you the PAC content per serving?
3. If no one can answer, treat the fruit-powder milligram as marketing weight, not a dose.

A defensible answer looks like a declared PAC number per serving, or a stated standardization such as a percentage of PACs by weight. An answer that only repeats the fruit-powder milligram does not tell you whether you are near the 36 mg threshold. This is not a criticism of any one brand. It is a category-wide gap, and it is why the FDA built its claim around fruit powder instead of PACs.

The FDA Qualified Health Claim, In Its Own Words

The FDA allows a qualified health claim for certain cranberry products, and the exact wording tells you how narrow the permission is [4].

For cranberry dietary supplements, the FDA permits the claim only when the product contains at least 500 mg of cranberry fruit powder, 100 percent fruit, per daily serving. The permitted wording is: "Consuming 500 mg each day of cranberry dietary supplement may help reduce the risk of recurrent urinary tract infection (UTI) in healthy women. FDA has concluded that there is limited scientific evidence supporting this claim" [4].

For juice beverages, the juice must be at least 27 percent cranberry juice, and the claim applies to one 8 ounce serving per day, with the FDA describing that evidence as limited and inconsistent.

Three details matter as much as the claim itself.

• It is a qualified claim, not an approved one. The FDA permits it only with a disclaimer attached, because the evidence does not meet the standard for an authorized health claim.
• The evidence differs by form. The FDA calls it "limited scientific evidence" for supplements and "limited and inconsistent" for juice [4].
• It covers a specific audience. The claim is for healthy women with a history of urinary tract infection, and it concerns recurrent risk, not treating an infection you already have.

The claim also excludes dried cranberries, cranberry sauce, and other conventional cranberry foods, because those are foods, not supplements. So when you see the FDA mentioned on a cranberry page, check whether the page quotes the claim accurately, with its 500 mg floor and its "limited scientific evidence" language, or stretches it into something the agency never said.

Form Matters: Capsules, Juice, Gummies, and Powder

Concentrated capsules and tablets are the practical route to a controllable daily fruit-powder amount, with one caveat worth knowing: NCCIH notes that processing cranberries into tablets or capsules can reduce the concentration of PACs, which can reduce a product's potential effectiveness [5].

• Capsules, tablets, and softgels. Concentrated, easy to standardize, and the form most trials used. This is where you have the best chance of a labeled fruit-powder amount, and occasionally a PAC figure.
• Juice. The FDA claim requires at least 27 percent cranberry juice and one 8 ounce serving per day [4]. Real cranberry juice is tart, so many "cranberry juice cocktails" add sugar, which is worth checking on the nutrition panel.
• Gummies. Convenient, but they typically carry less fruit material per serving, and often added sugar, so they are the hardest form to align with a research dose.
• Powder. Flexible and easy to scale, but you still face the same question: does the label tell you the PAC amount, or only the fruit-powder weight?

There is also a claim you will see on a lot of cranberry pages, that one serving of cranberry pills equals an 8 ounce glass of juice. That equivalence is about fruit material, not about PACs, so it is not a way to know your PAC dose. A pill and a glass can be called equivalent in fruit terms while delivering entirely different amounts of the compound the research measures.

The takeaway is simple. Pick the form whose label you can actually interrogate, which usually means capsules or tablets with a stated fruit-powder amount and a manufacturer who can answer the PAC question. Cleveland Clinic's drug monograph lists cranberry in capsule and tablet form and outlines the precautions to review first, a useful companion checklist when comparing products [6].

Who the Evidence Does and Does Not Support

The pooled evidence finds a benefit in some groups and no clear benefit in others, and the split is consistent enough to state plainly [1].

The 2023 Cochrane review included 50 trials and 8,857 participants. The 26 trials that could be pooled, covering 6,211 participants, found a reduction in the risk of symptomatic, culture-verified urinary tract infection overall, at a risk ratio of 0.70 (95% CI 0.58 to 0.84), rated moderate certainty [1]. That result is not spread evenly.

Where the evidence shows a signal:

• Women with recurrent urinary tract infections, the most studied group, at a risk ratio of 0.74 (95% CI 0.55 to 0.99) [1].
• Children, in the trials that enrolled them [1].
• People after a bladder intervention [1].

Where the evidence does not show a clear benefit:

• Elderly people in institutional care [1].
• Adults with neuromuscular bladder dysfunction [1].
• Pregnant women [1].

The FDA's claim lines up with this picture. It is written for healthy women with a history of urinary tract infection, not for the general population and not for the groups where the trials came back empty [4]. If you are in a group without a signal, that does not mean cranberry is harmful. It means the evidence does not support expecting the result the recurrent-infection trials found, and that is fair to weigh before you spend on a bottle.

Prevention, Not Treatment

Cranberry is studied to reduce recurrence risk, not to treat an infection you already have, and the treatment question has been reviewed and came back empty [3].

The Cochrane review on cranberry for treating urinary tract infections found no evidence from studies on the effects of cranberry juice or other cranberry products on established infections [3]. That review dates from 1998, so on its own it is old. NCCIH, writing from the current evidence, draws the same line and puts it more bluntly: cranberry "isn't recommended as a treatment for existing UTIs in any population" [5].

NCCIH adds the practical warning that goes with it: do not use cranberry in place of a proven treatment for a suspected infection [5].

So here is the rule, stated without hedging. A suspected urinary tract infection needs a clinician, not a supplement. Burning, urgency, or pelvic pressure, and especially fever, flank pain, or blood, are reasons to seek care promptly. Cranberry is not a substitute for a proven treatment, and nothing here should be read as one. Once an infection is properly treated and resolved, the prevention question becomes a different conversation, and that is the only conversation cranberry's evidence addresses.

Cranberry vs D-Mannose

Cranberry and D-mannose are both anti-adhesion strategies, but they work by different mechanisms and rest on different trial records, so they are not interchangeable [5].

D-mannose is a simple sugar that acts as a decoy, offering E. coli a mannose-shaped surface so the bacteria grab that instead of the bladder wall. Cranberry's PACs interfere with adhesion by a separate route, which is why the two are discussed together and why they are not the same product.

For the full picture on D-mannose, including why its largest trial came back null, see our guide to D-mannose for urinary tract health. That guide is the other half of this story: it explains the decoy mechanism, and this article explains the PAC side.

The contrast in evidence is real. Cochrane's cranberry review found a moderate-certainty risk reduction [1], while D-mannose's largest and most recent trial did not find a reduction, which is why the two ingredients do not carry equal weight in the research. Combination products that pair them also exist, and there is no known conflict because they act by separate mechanisms. What is missing is a trial that tested the combination against either one alone, so a combination is a reasonable convenience rather than a proven upgrade.

If you are choosing between them, the evidence favors cranberry. If you want both anti-adhesion routes in one bottle, the combination form is the way to do that.

Who Should Check With a Clinician First

Cranberry is generally well tolerated, but several situations call for a conversation with a clinician before you add it [5][6].

NCCIH reports that cranberry is generally safe when taken orally, and that large amounts can cause stomach upset and diarrhea, especially in young children [5]. Cleveland Clinic lists practical precautions worth reviewing first [6]. Go through this list honestly:

• Warfarin and other anticoagulants. NCCIH describes the evidence on a cranberry interaction as conflicting, which is why this is a check-first item rather than a clear yes or no [5].
• Kidney stones. Cleveland Clinic names kidney stones among the conditions to discuss with a clinician before using cranberry [6].
• Diabetes. Sugar content varies by product and form, so read the label and talk to your clinician, particularly with juice or gummies [6].
• Asthma. Cleveland Clinic lists asthma among the conditions to review first [6].
• Stomach or intestinal problems. Ongoing digestive issues are another listed precaution [6].
• Allergy to aspirin or to plants. A cranberry or plant allergy, or an aspirin sensitivity, is a reason to check first [6].
• Pregnancy and breastfeeding. NCCIH describes cranberry as safe at food amounts but notes that larger amounts are not established [5].
• Children. Cranberry appears in pediatric trials [1], but doses and products for children should be set with a clinician rather than guessed from an adult label.

None of this means cranberry is dangerous for most people. It means the honest version of "generally safe" comes with a short list of situations where the right move is to ask before you start.

How to Read a Cranberry Label

Read the label for the one number the research cares about, and treat everything else as context [8].

1. Look for a PAC figure or a PAC standardization. If the label declares PACs per serving, or a set percentage of PACs, you have the number the evidence is built on.
2. If there is no PAC figure, note the fruit-powder milligrams. This is useful context, but it is not a dose of the active compound [8].
3. Compare the fruit amount to the FDA floor. The qualified claim uses at least 500 mg of cranberry fruit powder, 100 percent fruit, per daily serving [4].
4. Check the serving count against the daily label. A product may say one capsule or two capsules per serving, and the fruit amount is tied to that serving.
5. For juice, check the percentage and the sugar. The FDA claim applies to juice that is at least 27 percent cranberry, and the nutrition panel shows any added sugar [4].
6. Ask the manufacturer the PAC question directly. If they can answer it, that is a good sign. If no one can, you have learned something useful about the product.

Work through those six steps and you will know more about a cranberry bottle than most of the pages selling it. The goal is not a perfect product. It is knowing whether you are anywhere near the dose the research describes, rather than guessing from a fruit-powder number.

Beyond Cranberry: A Broader Urinary and Gut Routine

Cranberry is one input, and the wider picture includes general urinary and specialty support plus the gut ecology that sits alongside it.

If you are building a routine rather than buying a single bottle, it helps to see where cranberry fits. The Specialty Support collection at Agape Nutrition gathers targeted formulas for needs that fall outside the everyday categories, including urinary and other focused support.

There is also a gut connection worth understanding. The bacteria that reach the urinary tract often originate in the digestive tract, so digestive and urinary health are not separate subjects. Agape's Digestion and Gastrointestinal Support collection is the place to look if that is the wider conversation you want to have.

Cranberry is one anti-adhesion tool among several, chosen with your eyes open about dose, while hydration and a clinician's guidance for any active infection remain the foundation.

What We Recommend

We stock cranberry in three forms, and we will tell you honestly what their labels do and do not declare.

Here is the honest note that ties this guide together. None of these three labels declares a PAC figure. That is not a flaw in any of them, and it is not unusual. It is the norm across the category, and it is exactly why the label checklist above exists. Ask the PAC question of any cranberry product you consider, ours included, and let the answer guide your choice.

References

1. Williams G, Stothart CI, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. 2023; Issue 11. Art. No.: CD001321. https://www.cochrane.org/evidence/CD001321_cranberries-preventing-urinary-tract-infections
2. Xiong Z, Gao Y, Yuan C, Jian Z, Wei X. Preventive effect of cranberries with high dose of proanthocyanidins on urinary tract infections: a meta-analysis and systematic review. Frontiers in Nutrition. 2024. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1422121/full
3. Jepson RG, Mihaljevic L, Craig JC. Cranberries for treating urinary tract infections. Cochrane Database of Systematic Reviews. 1998; Issue 4. Art. No.: CD001322. https://pmc.ncbi.nlm.nih.gov/articles/PMC7025796/
4. U.S. Food and Drug Administration. FDA announces qualified health claim for certain cranberry products and urinary tract infection. 21 July 2020.
5. National Center for Complementary and Integrative Health (NIH). Cranberry: Usefulness and Safety. https://www.nccih.nih.gov/health/cranberry
6. Cleveland Clinic. Cranberry Capsules or Tablets. https://my.clevelandclinic.org/health/drugs/19745-cranberry-capsules-or-tablets
7. McIntyre C, Johnston B. Cranberry: Uses, Side Effects, and More. WebMD. 2025. https://www.webmd.com/vitamins-supplements/cranberry
8. Cochrane Collaboration. Cranberries for preventing urinary tract infections, plain language summary. 2023.
9. Hayward G, et al. d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial. JAMA Internal Medicine. 2024;184(6):619-628. https://pmc.ncbi.nlm.nih.gov/articles/PMC11002776/

Frequently Asked Questions